AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Promising Preclinical Results With Immunotherapeutic Agent.(HIV vaccine research)

Vaccine Weekly

| October 10, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 OCT 10 - (NewsRx.com & NewsRx.net) --

CEL-SCI Corporation presented a poster at the AIDS Vaccine 2001 Congress held in Philadelphia, Pennsylvania entitled "C Clade HGP-30 (p17 aa 86-115) Based Peptide Conjugates as Potential Therapeutic and Prophylactic HIV-1 Vaccine Antigens."

In it, strong evidence of cellular immune responses and recognition of different strains of the AIDS virus was reported. The immunotherapeutic agent (L.E.A.P.S. conjugate) combines a peptide sequence representing a region of the HIV-1 core protein, p17, with a peptide designed to induce a cellular immune response against the HIV peptide.

The evaluation of the L.E.A.P.S. conjugates was conducted in mice and the antibody responses induced by vaccination were assessed for their abilities to bind to peptide sequences representing the major clades (strains) of HIV found worldwide, A, B, C, D, and E. It was found that one of the conjugates, which included the C clade sequence of HGP-30, induced antibodies which showed significant cross clade recognition. Significant titers of immunoglobulin G (IgG)2a subtype antibodies, an antibody associated with the induction of cellular TH1 immune responses, were also observed with this same conjugate.

Dr. Dan Zimmerman, of CEL-SCI, and inventor of the technology said, "We have combined our L.E.A.P.S. and HGP-30 technologies to design a potential vaccine antigen which we believe targets specific types of immune cells and elicits the most appropriate responses against HIV-1. The goal of this work is to develop a prototype formulation which will be cheap to make and easy to administer. Such a ...

Related articles from newspapers, magazines, journals, and more
Papillomavirus-HIV-1 gp41 virus-like particles induce HIV antibodies.
Newspaper article from: Vaccine Weekly October 6, 2004 700+ words
...immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine papillomavirus-HIV-1 gp41 chimeric virus-like...major subject areas of AIDS and HIV Vaccine, Vaccine Development...This article was prepared by Vaccine Weekly editors from staff and other...
HIV/AIDS disproportionately affects African American women.
Newspaper article from: Vaccine Weekly June 16, 2004 700+ words
...and dispel the myths about HIV vaccine research, the Black...Imperative says. Developing an HIV vaccine depends upon individuals...vision of the world without HIV/AIDS. This article was prepared by Vaccine Weekly editors from staff and other...
HIV vaccine trial moving to enroll last cohort of volunteers.
Newspaper article from: Vaccine Weekly October 20, 2004 700+ words
...by UMMS and ABL. To date, the HIV vaccine project has been funded under a 5-year HIV Vaccine Design and Development...prevent this worldwide epidemic of HIV/AIDS." This article was prepared by Vaccine Weekly editors from staff and other reports...
HIV-1 Plasmid Antigens and IL-12-Expressing Plasmids Key...
Newspaper article from: Vaccine Weekly November 1, 2000 700+ words
...HIV infected chimpanzees using HIV-1 plasmid antigens and interleukin...1522). "Immunization of HIV-1 infected chimpanzees with...online database using the terms "HIV" and "vaccine" and "plasmid...This article was prepared by Vaccine Weekly editors from staff and other...
HIV-1 Immunogen Stimulates HIV Specific Responses.(Brief Article)
Newspaper article from: Vaccine Weekly October 18, 2000 700+ words
...HIV infected patients * The HIV-1 immunogen was whole-killed gp120-depleted HIV-1 in IFA and goes by the...Remune, patients elicited HIV specific immune responses...This article was prepared by Vaccine Weekly editors from staff and other...
Antibody Responses Absent in HIV Exposed Uninfected Sex Workers.
Newspaper article from: Vaccine Weekly August 16, 2000 700+ words
...immunoglobulin E responses against HIV-1 or HIV-2 * As such, researchers determined that resistance to HIV infection can occur without the...virus This article was prepared by Vaccine Weekly editors from staff and other reports...
On demand HIV/AIDS Radio Network launched on World AIDS Day.
Newspaper article from: Vaccine Weekly December 29, 2004 700+ words
...network of affiliate web sites. HIV and Me Talk Radio is hosted by Timothy Critzer, HIV-positive author, columnist...Jackstreet Media and is part of the HIV and Me Educational Series...This article was prepared by Vaccine Weekly editors from staff and other...
Non-neutralizing anti-HIV-1 antibody becomes neutralizing antibody.
Newspaper article from: Vaccine Weekly December 15, 2004 700+ words
...expressed on the surface of HIV-1-susceptible cells: A new way to fight HIV. J Immunol, 2004;173...subject areas of AIDS and HIV Vaccine, Vaccine Development...This article was prepared by Vaccine Weekly editors from staff and other...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA